ClinicalTrials.gg
Sign In

Neoplastic Cells, Circulating clinical trials

The registry lists 227 studies for Neoplastic Cells, Circulating across more than 10 countries. 54 are recruiting or about to start. 64 of them are mainly about Neoplastic Cells, Circulating (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Neoplastic Cells, Circulating studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
80
Status unknown
63
Recruiting
45
Active, not recruiting
14
Terminated
10
Not yet recruiting
9

Phase

Phase 2
23
Phase 3
7
Phase 4
6
Early Phase 1
3
Phase 1
2

Where

China
48
United States
33
France
31
Taiwan
24
Canada
9
Germany
9

Who runs them

Chang Gung Memorial Hospital (15) · University Hospital, Montpellier (10) · Fuda Cancer Hospital, Guangzhou (7) · Fudan University (6) · The Institute of Molecular and Translational Medicine, Czech Republic (5) · RenJi Hospital (5) · AC Camargo Cancer Center (5) · UNC Lineberger Comprehensive Cancer Center (4)

What is being tested here

Drugs under test in Neoplastic Cells, Circulating studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Propofol103
Bevacizumab113
Paclitaxel102
Carboplatin102
Cyclophosphamide102
Aspirin102
Epirubicin102
Capecitabine111
Sevoflurane101
Pertuzumab101

Drug classes tested here Antimitotic agents 1 open · Antimetabolites 1 open · Inhaled anesthetics 1 open

Coming up

3phase 3 studies under way
16studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 45 Neoplastic Cells, Circulating studies recruiting now, 28 (62%) set no upper age limit and 9 (20%) stop at 75 or younger. 4 (9%) take children under 18. 7 (16%) are for women only and 6 (13%) for men only; 8 (18%) take healthy volunteers.

Recruiting studies that take each age, of 45
AgeWomenMen
104 (9%)4 (9%)
1835 (78%)32 (71%)
3037 (82%)35 (78%)
4038 (84%)36 (80%)
5038 (84%)37 (82%)
6537 (82%)37 (82%)
7534 (76%)36 (80%)
8528 (62%)29 (64%)

Across all 227 studies, recruiting or not: 18% stop at 75 or younger and 2% at 65; 5% take children; 14% are for women only and 8% for men only; 21% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neoplastic Cells, Circulating studies take

Of 59 observational studies under Neoplastic Cells, Circulating, half reached primary completion within 93 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase41 mo23–84 · 42 studies—41 mo23–84 · 40 studies
Observational93 mo38–… · 59 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 227. Browse all 227 → or search them.